Global $2.62 Bn Proteasome Inhibitors Markets, 2017-2022, 2022-2027F, 2032F: Focus on Velcade, Kyprolis, Ninlaro, Bortezomib, Carfilzomib, & Ixazomib
16. Oktober 2023 07:43 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Proteasome Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global proteasome inhibitors market is...
Global CAR-T Pipeline Insight Report 2020: Overview, Landscape, Therapeutic Assessment, Current Treatment Scenario and Emerging Therapies
30. Dezember 2020 04:38 ET
|
Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "CAR-T - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "CAR-T - Pipeline Insight, 2020," report...
Advancements in Technologies Driving the Growth of Proteasome Inhibitor Therapeutics Pipeline: P&S Market Research
14. Februar 2018 01:29 ET
|
P&S Market Research
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- According to a new research report titled “Proteasome Inhibitors Therapeutics Pipeline, 2017 - Clinical Trials & Results, Patents, Designations,...